Skip to main content

Table 4 Differences between patients with and without dementia in the COVID-19 group, not adjusted for sex or age. Analysed with chi-2 test

From: Symptoms, symptom relief and support in COVID-19 patients dying in hospitals during the first pandemic wave

Characteristics

Dementia

No dementia

χ2

P-value

Breathlessness occurrencea

60/93 (65%)

893/1231 (73%)

2.8

.097

Anxiety occurrencea

47/80 (59%)

778/1109 (70%)

4.6

.033

Delirium occurrencea

47/83 (57%)

386/1007 (38%)

10.7

.001

Respiratory secretions occurrencea

36/98 (37%)

595/1259 (47%)

4.0

.044

Nausea occurrencea

6/80 (8%)

94/942 (10%)

0.5

.47

Pain occurrencea

59/92 (64%)

727/1191 (61%)

0.3

.56

Close friend(s) and/or relative(s) present with or without staff at the time of deatha

23/99 (23%)

343/1320 (26%)

0.4

.55

Someone present at the time of deatha

49/99 (50%)

756/1320 (57%)

2.3

.13

Parenteral fluids/nutrition or enteral-tube feeding given during the last 24 hoursa

31/100 (31%)

504/1333 (38%)

1.8

.18

  1. aDon’t know” was an optional answer for the questions on symptom occurrence, and these responses were excluded from the analysis. Therefore, numbers do not sum to group totals